[1]
J. P. F. Remédio Marques, “The scope of patent rights for new medical indications of known substances or compounds and the regulatory marketing authorization for a generic version of the pharmaceutical for a different therapeutic indication”, PIDCC, vol. 3, no. 1, pp. 323–370, Feb. 2014, doi: 10.16928/2316-8080.v5n1p.323-370.